Physician

Jose A Velez, MD

According to 2025 Medicare claims, Jose Velez, MD (NPI: 1578744538) practices nephrology in the Eagle Pass, TX market, with the plurality of this provider's patient population coming from Maverick, TX. This provider's primary affiliated billing organization is RENAL ASSOCIATES, P.A. (NPI: 1851368112; TIN: 742083988) and primary practice location at 78852-5884. Velez is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Velez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 354 traditional Medicare patients, billed 2,687 HCPCS/CPT codes, and received $176,245 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,956 prescription claims across 280 beneficiaries totaling $575,497 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 196 claims. Open Payments data shows 33 records totaling $1,020. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $372,476 to $176,245. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	698	6,171	$372,476
2016	936	3,670	$323,586
2017	885	4,157	$340,839
2018	812	4,489	$347,897
2019	772	4,423	$348,791
2020	635	3,588	$320,289
2021	533	3,464	$306,882
2022	436	2,952	$249,235
2023	418	2,474	$195,291
2024	354	2,687	$176,245

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	471	4,695	$641,459
2016	392	2,490	$678,091
2017	302	1,819	$593,881
2018	311	1,775	$359,643
2019	264	1,528	$274,738
2020	243	1,551	$302,591
2021	254	1,722	$410,093
2022	258	1,926	$452,994
2023	244	1,715	$598,338
2024	280	1,956	$575,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	52	298	$12,492
2016	162	473	$23,747
2017	147	428	$20,840
2018	41	228	$17,028
2019	N/R	242	$7,655
2020	N/R	258	$8,025
2021	N/R	157	$4,056
2022	N/R	161	$3,430
2023	N/R	161	$2,802
2024	N/R	196	$2,985

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	89	260	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	150	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	86	177	$58
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	104	210	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	106	284	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	121	6,540	$118,045
Velphoro	Sucroferric Oxyhydroxide	46	1,500	$117,224
Auryxia	Ferric Citrate	46	1,980	$93,218
Jardiance	Empagliflozin	47	2,550	$51,041
Ozempic	Semaglutide	39	1,346	$42,312

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	40	$883
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	47	$837
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	46	$677
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	47	$575
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	16	$13

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$1,020	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jose A. Velez, MD?

Tedicare shows public-source Medicare data for Jose A. Velez, MD (NPI 1578744538), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jose A. Velez, MD have ACO affiliation data?

Jose A. Velez, MD is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jose A. Velez, MD?

Jose A. Velez, MD is linked to RENAL ASSOCIATES, P.A. (billing NPI 1851368112) in the available physician profile data.

Does Jose A. Velez, MD have Open Payments data?

Jose A. Velez, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.